A comparative analysis of 23 structures of the amyloidogenic protein transthyretin
- PMID: 10986125
- DOI: 10.1006/jmbi.2000.4078
A comparative analysis of 23 structures of the amyloidogenic protein transthyretin
Abstract
Self-assembly of the human plasma protein transthyretin (TTR) into unbranched insoluble amyloid fibrils occurs as a result of point mutations that destabilize the molecule, leading to conformational changes. The tertiary structure of native soluble TTR and many of its disease-causing mutants have been determined. Several independent studies by X-ray crystallography have suggested structural differences between TTR variants which are claimed to be of significance for amyloid formation. As these changes are minor and not consistent between the studies, we have compared all TTR structures available at the protein data bank including three wild-types, three non-amyloidogenic mutants, seven amyloidogenic mutants and nine complexes. The reference for this study is a new 1.5 A resolution structure of human wild-type TTR refined to an R-factor/R-free of 18.6 %/21.6 %. The present findings are discussed in the light of the previous structural studies of TTR variants, and show the reported structural differences to be non-significant.
Copyright 2000 Academic Press.
Similar articles
-
Intrinsic versus mutation dependent instability/flexibility: a comparative analysis of the structure and dynamics of wild-type transthyretin and its pathogenic variants.J Struct Biol. 2004 Nov;148(2):153-68. doi: 10.1016/j.jsb.2004.06.007. J Struct Biol. 2004. PMID: 15477096
-
Search for intermediate structures in transthyretin fibrillogenesis: soluble tetrameric Tyr78Phe TTR expresses a specific epitope present only in amyloid fibrils.J Mol Biol. 2000 Dec 1;304(3):461-70. doi: 10.1006/jmbi.2000.4220. J Mol Biol. 2000. PMID: 11090287
-
Acidic pH-induced conformational changes in amyloidogenic mutant transthyretin.J Mol Biol. 2007 Feb 23;366(3):711-9. doi: 10.1016/j.jmb.2006.11.076. Epub 2006 Dec 1. J Mol Biol. 2007. PMID: 17196219
-
Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategies.J Struct Biol. 2000 Jun;130(2-3):290-9. doi: 10.1006/jsbi.2000.4273. J Struct Biol. 2000. PMID: 10940233 Review.
-
New therapeutic approaches for familial amyloidotic polyneuropathy (FAP).Amyloid. 2003 Aug;10 Suppl 1:55-66. Amyloid. 2003. PMID: 14640043 Review.
Cited by
-
Inhibition of human transthyretin aggregation by non-steroidal anti-inflammatory compounds: a structural and thermodynamic analysis.Int J Mol Sci. 2013 Mar 6;14(3):5284-311. doi: 10.3390/ijms14035284. Int J Mol Sci. 2013. PMID: 23466880 Free PMC article.
-
Development of a Highly Potent Transthyretin Amyloidogenesis Inhibitor: Design, Synthesis, and Evaluation.J Med Chem. 2022 Nov 10;65(21):14673-14691. doi: 10.1021/acs.jmedchem.2c01195. Epub 2022 Oct 28. J Med Chem. 2022. PMID: 36306808 Free PMC article.
-
Structural and functional analysis of PucM, a hydrolase in the ureide pathway and a member of the transthyretin-related protein family.Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):9790-5. doi: 10.1073/pnas.0600523103. Epub 2006 Jun 16. Proc Natl Acad Sci U S A. 2006. PMID: 16782815 Free PMC article.
-
Heating of proteins as a means of improving crystallization: a successful case study on a highly amyloidogenic triple mutant of human transthyretin.Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Aug 1;63(Pt 8):695-700. doi: 10.1107/S1744309107033957. Epub 2007 Jul 21. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007. PMID: 17671371 Free PMC article.
-
A molecular mechanism for transthyretin amyloidogenesis.Nat Commun. 2019 Feb 25;10(1):925. doi: 10.1038/s41467-019-08609-z. Nat Commun. 2019. PMID: 30804345 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous
